INTANGIBLE ASSETS (Details Narrative)	3 Months Ended		9 Months Ended
	Sep. 30, 2017 USD ($) Number	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) Number	Sep. 30, 2016 USD ($)
Finite-Lived Intangible Assets [Line Items]
Amortization expense | $	$ 18,433	$ 13,917	$ 52,321	$ 38,560
Number of issued patents	17		17
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life			20 years
Utility Patent Progesterone and Estradiol Products [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	13		13
Utility Patent TX-004HR [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	2		2
Utility Patent Pipeline Transdermal Patch Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1		1
Opera Software Patent [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1		1